Latest Breaking News On - Larimar therapeutics inc - Page 13 : comparemela.com

Larimar Therapeutics Receives FDA Clearance to Proceed to 50 mg Cohort in CTI-1601 s Phase 2 Friedreich s Ataxia Trial and to Initiate Open Label Extension Trial Seite 1

Larimar Therapeutics Receives FDA Clearance to Proceed to 50 mg Cohort in CTI-1601 s Phase 2 Friedreich s Ataxia Trial and to Initiate Open Label Extension Trial Seite 1
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Carole ben maimonDrug administrationLarimar therapeutics incChief executive officer

LRMR Stock Price | Larimar Therapeutics Inc Stock Quote (U S : Nasdaq)

LRMR | Complete Larimar Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Bala cynwydLarimar therapeutics incLarimar therapeuticsRmr analyst estimatesRmr earnings estimatesRmr share estimatesRmr analyst recommendationsRmr ratingsArimar therapeutics inc analyst estimatesArimar therapeutics inc earnings estimatesArimar therapeutics inc analyst recommendationsArimar therapeutics inc analyst ratings

Larimar Therapeutics Appoints Dr Rusty Clayton as Chief Medical Officer

Larimar Therapeutics Appoints Dr Rusty Clayton as Chief Medical Officer
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesJoyce allaireNancym ruizCarole ben maimonMichael celanoGopi shankarPhiladelphia college of osteopathic medicineExchange commissionCo incLarimar therapeutics incCompany contactPrincipal at aeremedeaLarimar therapeuticsChief medical officerScientific advisoryChief development officer

Short Interest in Larimar Therapeutics, Inc (NASDAQ:LRMR) Increases By 296 3%

Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 594,100 shares, an increase of 296.3% from the June 15th total of 149,900 shares. Based on an average trading volume of 276,600 shares, […]

Charles schwab investment management incConnor clark lunn investment management ltdCubist systematic strategiesLarimar therapeutics incVerition fund managementCheyne capital management united kingdomLarimar therapeuticsGet free reportFund managementLunn investment managementCapital management united kingdomSystematic strategiesCharles schwab investment managementLarimar therapeutics daily

Short Interest in Larimar Therapeutics, Inc (NASDAQ:LRMR) Increases By 296 3%

Short Interest in Larimar Therapeutics, Inc (NASDAQ:LRMR) Increases By 296 3%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Larimar therapeutics incCubist systematic strategiesVerition fund managementCheyne capital management united kingdomCharles schwab investment management incConnor clark lunn investment management ltdLarimar therapeuticsGet free reportFund managementLunn investment managementCapital management united kingdomSystematic strategiesCharles schwab investment managementLarimar therapeutics daily